series-a
Stage
2
Investors
About
Aradigm provides a novel financial and delivery model to enable sustainable access and affordable pricing for cell and gene therapies, addressing challenges faced by payers, providers, manufacturers, and patients.
Explore Aradigm's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.